Incyte INCY Business Segments — Total revenues
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Incyte in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The official record: Incyte’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →
Ask your AI about Incyte's business segments — total revenues.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Incyte's business segments — total revenues?
- Incyte (INCY) reported business segments — total revenues of $1.27B in Q1 2026.
- How has Incyte's business segments — total revenues changed year-over-year?
- Incyte's business segments — total revenues increased by 20.9% year-over-year, from $1.05B to $1.27B.
- What is the long-term trend for Incyte's business segments — total revenues?
- Over 3 years (2022 to 2025), Incyte's business segments — total revenues has grown at a 14.8% compound annual growth rate (CAGR), from $3.39B to $5.14B.
- What does business segments — total revenues mean?
- This represents the aggregate gross income generated by the company's primary business segment through product sales, royalties, and collaboration agreements. It serves as the top-line indicator of market demand for the company's therapeutic portfolio and the effectiveness of its commercialization strategy.